The Next Steps in Developing Clinical Practice Guidelines for Prevention

• Published in: Journal of the American College of Cardiology Vol. 62; no. 15; pp. 1399 - 1400
• Main Authors: Gibbons, Gary H., MD, Harold, John Gordon, MD, MACC, MACP, Jessup, Mariell, MD, FAHA, Robertson, Rose Marie, MD, FAHA, Oetgen, William J., MD, MBA, MBA, FACC, FACP
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 08-10-2013; Elsevier; Elsevier Limited
• Subjects: ACCF; AHA; Biological and medical sciences; Cardiology; Cardiology. Vascular system; Cardiovascular; cardiovascular disease; Cardiovascular Diseases - prevention & control; Clinical medicine; clinical practice guidelines; Cooperative Behavior; Health risk assessment; Heart; Humans; Internal Medicine; Medical sciences; National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division; National Heart, Lung, and Blood Institute (U.S.); NHLBI; Practice Guidelines as Topic; prevention; Review Literature as Topic; Risk assessment; Societies, Medical; systematic evidence review; United States; clinical practice guidelines; cardiovascular disease; NHLBI; systematic evidence review; AHA; ACCF; prevention; Prevention; Cardiovascular disease; Circulatory system; Cardiology; Professional practice; Recommendation
• ISSN: 0735-1097; 1558-3597
• DOI: 10.1016/j.jacc.2013.08.004

Recognizing the Institute of Medicine's recommendation that the CPG development process be bifurcated into the generation of systematic reviews of the evidence (2), the identification of clinical questions, and the proffering of clinical recommendations (3), we are utilizing these processes in our own joint CPGs. [...]we feel it is entirely appropriate that the NHLBI has decided to focus its resources and expertise on evaluation of the available research evidence via the systematic review function, while entrusting us with the processes leading to CPG development.